Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/1/2020
SIETES contiene 92880 citas

 
 
 1 a 20 de 123 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Branch-Elliman W, O'Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surgery 2019:24 de abril. [Ref.ID 103091]
2. Cita con resumen
Taylor P. Finch’s microbiota drug for C. diff gets FDA breakthrough status. PMLiVE 2019:11 de febrero. [Ref.ID 103019]
3.Enlace a cita original Cita con resumen
Goldenberg JZ, Mertz D, Johnston BC. Probiotics to prevent Clostridium difficile Infection in patients receiving antibiotics. JAMA 2018;320:7 de agosto. [Ref.ID 102829]
5. Cita con resumen
Cook D, Guyatt G. Prophylaxis against upper gastrointestinal bleeding in hospitalized patients. N Engl J Med 2018;378:2506-16. [Ref.ID 102735]
6.Enlace a cita original Cita con resumen
Juul FE, Garborg K, Bretthauer M, Skudal H, Øines MN, Wiig H, Rose O, Seip B, Lamont JT, Midtvedt T, Valeur J, Kalager M, Helsingen L, Løberg M, Adami H-O. Fecal microbiota transplantation for primary Clostridium difficile infection. N Engl J Med 2018;378:28 de junio. [Ref.ID 102689]
8. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
9.Enlace a cita original Cita con resumen
Goldenberg JZ, Yap C, Lytvyn L, Ka-Fung Lo C, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews 2018;12:19 de diciembre. [Ref.ID 102470]
11. Cita con resumen
Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017;177:1308-15. [Ref.ID 102042]
12. Cita con resumen
Ma GK, Brensinger CM, Wu Q, Lewis JD. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study. Ann Intern Med 2017;167:152-8. [Ref.ID 101991]
13. Cita con resumen
Wei L, Ratnayake L, Phillips G, McGuigan CC, Morant SV, Flynn RW, Mackenzie IS, MacDonald TM. Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study. Br J Clin Pharmacol 2017;83:1298-308. [Ref.ID 101942]
14. Cita con resumen
Tariq R, Singh S, Gupta A, Pardi DS, Khanna S. Association of gastric acid suppression with recurrent Clostridium difficile infection: a systematic review and meta-analysis. JAMA Intern Med 2017;177:784-91. [Ref.ID 101618]
15.Enlace a cita original Cita con resumen
Tariq R, Singh S, Gupta A, Pardi DS, Khanna S. Association of gastric acid suppression with recurrent Clostridium difficile infection. A systematic review and meta-analysis. JAMA Intern Med 2017;177:784-91. [Ref.ID 101506]
16. Cita con resumen
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim Y-S, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr M-B, for the MODIFY I and MODIFY II Investigators. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med 2017;376:305-17. [Ref.ID 101394]
17. Cita con resumen
Selvanderan SP, Summers MJ, Finnis ME, Plummer MP, Ali Abdelhamid Y, Anderson MB, Chapman MJ, Rayner CK, Deane AM. Pantoprazole or placebo for stress ulcer prophylaxis (POP-UP): randomized double-blind exploratory study. Crit Care Med 2016;44:1842-50. [Ref.ID 100852]
18. Cita con resumen
Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, Bakow B, Curran P, McKenney J, Tisch A, Reinert SE, Machan JT, Brandt LJ. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med 2016:23 de agosto. [Ref.ID 100599]
20.Enlace a cita originalTiene citas relacionadas Cita con resumen
Schoenfeld AJ, Grady D. Adverse effects associated with proton pump inhibitors. JAMA Intern Med 2016;176:febrero. [Ref.ID 99958]
Seleccionar todas
 
 1 a 20 de 123 siguiente >>